|
RezipasDrug - Rezipas The trade name of the product as shown on the labeling.
Dosage -
POWDER; ORAL
Active Ingredient(s) -
Aminosalicylic Acid Resin Complex
Strength -
EQ 500MG BASE/GM
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
009052
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Myers Squibb Co
Rezipas
Rezipas Eq 500mg Base/gm Powder; Oral
Sodium Aminosalicylate 100% Powder; Oral Parasal Sodium 1gm Tablet; Oral Parasal Sodium 500mg Tablet; Oral Sodium P.A.S. 500mg Tablet; Oral Teebacin 500mg Tablet; Oral Neopasalate 846mg;112mg Tablet; Oral Paser 4gm/packet Granule, Delayed Release; Oral Parasal 1gm Tablet; Oral Parasal 500mg Tablet; Oral NewDrugInformation |